HK Stock Movement | ADICON HOLDINGS (09860) Closes Up Over 9% as Goldman Sachs Sees Recovery Signs in Diagnostic Sector, Outperforming ICL Peers

Stock News11-03

ADICON HOLDINGS (09860) surged over 13% during the session and closed up 9.27% at HK$6.6, with a turnover of HK$41.53 million. The rally followed a Goldman Sachs research report indicating early signs of recovery in China's diagnostic sector, including independent clinical laboratories (ICL) and in-vitro diagnostic (IVD) companies, in Q3 2025.

In the ICL segment, both KingMed Diagnostics and Dian Diagnostics reported improved operating cash flow, sequential revenue growth, and expanded margins, though neither met revenue targets. Goldman Sachs views these trends as evidence of industry consolidation. CITIC Securities also noted narrowing revenue declines in the ICL sector for Q3 2025, though profits remained impacted by impairments. The firm highlighted uncertainty in ICL growth but emphasized that companies with strong cost and quality control could gain market share.

Among leading ICL players, ADICON HOLDINGS posted the strongest net profit of RMB 43 million with gross profit reaching RMB 450 million in H1, while Dian Diagnostics returned to profitability with RMB 10.27 million net income. KingMed remained loss-making during the period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment